Riesgo de enfermedades infecciosas transmitidas por transfusión en el Valle del Cauca, Colombia

Colombia Medica

Volumn 30, Issue 1, 1999, Pages 13-18

  Cortés, B Armando ^a,b   Beltrán, Mauricio ^c   Olaya, Beatriz ^d   Hernández, Marlene ^e  

^a UNIVERSIDAD DEL VALLE   (Colombia)

^b Banco de Sangre   (Colombia)

^c INSTITUTO NACIONAL DE SALUD   (Colombia)

^d Laboratorio de Salud Publica Departamental   (Colombia)

^e Laboratorio de Salud Pública Municipal   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 32044438603     PISSN: 16579534     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Cortés A, Beltrán M, Olaya B, Hernández M. Epidemiología de la colección, proceso y uso de sangre y componentes sanguíneos en el Valle del Cauca, Colombia. Colombia Med 1999; 30: 5-12.
2. Cortés A, Rojas NP. Prevalencia de marcadores para infecciones trasmitidas por transfusión en diferentes tipos de donantes en Cali. Rev Med Transfusional 1994; 1: 10-3.
3. Ministerio de Salud de Colombia. Decreto 1571 Reglamentario de las actividades de los banos de sangre y servicios de transfusión. Santa Fe de Bogotá, agosto de 1993.
4. Lackritz EM, Satten GA, Aberle-Grasse J, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Eng J Med 1995; 333: 1721-25.
5. Schreiber GB, Busch MP, Kleinman SH, et al. The risk of transfusion-transmitted viral infections. The retrovirus epidemiology blood donors study. N Engl J Med 1996; 334: 1685-90.
6. Van de Poel CI, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994; 334: 1475-79.
7. Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang 1984; 46: 755-57.
8. Manns A, Wilks RJ, Murphy EL, et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer 1992; 51: 886-91.
9. Andrade ANS, Martelli CMT, Luquetti AO, et al. Triagem sorologica o Trypanosoma cruzi entre doadores de sangue do Brasil central. Bol Oficina Sanit Panam 1992; 113: 19-27.
10. Lorca MH, Child RB, Garcia AC, et al. Evaluación de reactivos comerciales empleados en el diagnóstico de la enfermedad de Chagas en bancos de sangre de Chile. I Selección de reactivos. Rev Med Chile 1992; 120: 420-26.
11. Donegan E, Stuart M, Niland JC, et al. Infection with human immuno-deficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med 1990; 113: 733-39.
12. Gocke DJ. A prospective study of post-transfusional hepatitis. JAMA 1972; 219: 1165-70.
13. Aach RD, Stevens CE, Hollinger FB, et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first-and second-generation assay. N Eng J Med 1991; 325: 1325-29.
14. World Health Organization. The control of Chagas disease. Geneva: WHO Tech Rep Ser N° 811: 32; 1990.
15. Cortés A, Rosado R, Castrillón L. Sensibilidad y especificidad comparativa en pruebas serológicas. Colombia Med 1993; 24: 18-21.
16. Busch MO, Lee LL, Satten GA, et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion; implications for screening of blood and tissue donors. Transfusion 1995; 35: 91-7.
17. Vrielink H, Reesink HW, Zaaijer HL, et al. Sensivity and specificity of four assays to detect human T-lymphotropic virus type I or type I/II antibodies. Transfusion 1996; 36: 344-46.
18. Kleinman S, Alter H, Busch M, et al. Increased detection of hepatitis C virus (VHC)-infected blood donors by a multiple-antigen VHC enzyme immunoassay. Transfusion 1992; 32: 805-13.
19. McOmish F, Chan SW, Dow BC, et al. Detection of three types of hepattits C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine amino-transferase abnormalities. Transfusion 1993; 53: 7-13.
20. Nelson KE, Ahmed F, Stambolis V, et al. Incident hepatitis C virus (VHC) and hepatitis B virus (HBV) infections intransfused cardiac surgery patients: infection rates during different methods of donor screening. Programs and Abstracts Book, NIH Consensus Development Conference: Infectious Disease Testing for Blood Transfusions, Bethesda, January 1995: 67-9.
21. Vyas GN, Rawal BP. The risk of HIV transmission by screened blood. N Engl J Med 1996; 334: 992-93.
22. McCullough J. The nation's changing blood supply system. JAMA 1993; 269: 2239-45.
23. Pedersen C, Lindhardt BO, Jensen BL, et al. Clinical course of primary HIV infection: consequence for subsequent course of infection. BJM 1989; 299: 154-47.
24. Alter M. Residual risk of transfusion associated hepatitis. In: Program and Abstract of the National Institutes of Health Development Conference on Infectious Disease Testing for Blood Transfusions. 1995 Jan 9-11; Bethesda; National Institute of Health; 1995. Pp. 23-7.
25. National Institute of Health. Infectious disease testing for blood transfusion. NIH Consens Statement 1995; 13: 13-4.
26. Schmunis GA. Trypanosoma cruzi the etiologic agent of Chagas disease: status in the blood supply in endemic and non endemic countries. Transfusion 1991; 31: 547-55.
27. Mosley JW, Huang W, Stram DO, et al. Donor level of serum alanine amino-transferase activity and antibody to hepatitis B core antigen associated with recipients hepatitis C and non-B, non-C outcomes. Transfusion 1996; 36: 776-81.
28. Korelitz JJ, Busch MO, Kleinman SH, et al. Relationship between antibody to hepatitis B core antigen and retroviral infections in blood from volunteer donors. Transfusion 1996; 36: 232-37.